ZNF451 anticorps
-
- Antigène Voir toutes ZNF451 Anticorps
- ZNF451 (Zinc Finger Protein 451 (ZNF451))
-
Reactivité
- Humain, Rat, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ZNF451 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein of human ZNF451 (NP_001026794.1).
- Isotype
- IgG
- Top Product
- Discover our top product ZNF451 Anticorps primaire
-
anti-Zinc Finger Protein 451 (ZNF451) (AA 81-110), (N-Term) antibody
ZNF451 Reactivité: Humain WB Hôte: Lapin Polyclonal RB24130 unconjugated
anti-Zinc Finger Protein 451 (ZNF451) (AA 600-900) antibodyZNF451 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
anti-Zinc Finger Protein 451 (ZNF451) (C-Term) antibodyZNF451 Reactivité: Humain, Rat, Souris, Chien, Porc, Lapin, Cheval, Roussette (Chauve-souris), Singe WB, IHC, IHC (p) Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- WB 1:200-1:2000
- Restrictions
- For Research Use only
-
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- ZNF451 (Zinc Finger Protein 451 (ZNF451))
- Autre désignation
- ZNF451 (ZNF451 Produits)
- Synonymes
- anticorps COASTER, anticorps dJ417I1.1, anticorps 4930515K21Rik, anticorps 4933435G09Rik, anticorps AI596398, anticorps Kiaa0576-hp, anticorps Znf451, anticorps mKIAA1702, anticorps zinc finger protein 451, anticorps ZNF451, anticorps Zfp451
- Sujet
- ZNF451,COASTER,dJ417I1.1,E3 SUMO-protein ligase, has a preference for SUMO2 and SUMO3 and facilitates UBE2I/UBC9-mediated sumoylation of target proteins (PubMed:26524493, PubMed:26524494). Plays a role in protein SUMO2 modification in response to stress caused by DNA damage and by proteasome inhibitors (in vitro). Required for MCM4 sumoylation (By similarity). Has no activity with SUMO1 (PubMed:26524493). Preferentially transfers an additional SUMO2 chain onto the SUMO2 consensus site 'Lys-11' (PubMed:26524493). Negatively regulates transcriptional activation mediated by the SMAD4 complex in response to TGF-beta signaling. Inhibits EP300-mediated acetylation of histone H3 at 'Lys-9'. Plays a role in regulating the transcription of AR targets.
- Poids moléculaire
-
Observed_MW: Refer to figures
Calculated_MW: 63 kDa/115 kDa/121 kDa
- ID gène
- 26036
- UniProt
- Q9Y4E5
-
